Paracetamol Use in Patients With Osteoarthritis and Lower Back Pain: Infodemiology Study and Observational Analysis of Electronic Medical Record Data
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Lower back pain (LBP) and osteoarthritis (OA) are common musculoskeletal disorders and account for around 17.0% of years lived with disability worldwide; however, there is a lack of real-world data on these conditions. Paracetamol brands are frequently prescribed in France for musculoskeletal pain and include Doliprane, Dafalgan, and Ixprim (tramadol-paracetamol). Objective: The objective of this retrospective study was to understand the journey of patients with LBP or OA when treated with paracetamol. Methods: Three studies were undertaken. Two studies analyzed electronic medical records from general practitioners (GPs) and rheumatologists of patients with OA or LBP, who had received at least one paracetamol prescription between 2013 and 2018 in France. Data were extracted, anonymized, and stratified by gender, age, and provider specialty. The third study, an infodemiology study, analyzed associations between terms used on public medical forums and Twitter in France and the United States for OA only. Results: In the first 2 studies, among patients with LBP (98,998), most (n=92,068, 93.0%) saw a GP, and Doliprane was a first-line therapy for 87.0% (n=86,128) of patients (71.0% [n=61,151] in combination with nonsteroidal anti-inflammatory drugs [NSAIDs] or opioids). Among patients with OA (99,997), most (n=84,997, 85.0%) saw a GP, and Doliprane was a first-line therapy for 83.0% (n=82,998) of patients (62.0% [n=51,459] in combination). Overall, paracetamol monotherapy prescriptions decreased as episodes increased. In the third study, in line with available literature, the data confirmed that the prevalence of OA increases with age (91.5% [212,875/232,650] above 41 years), OA is more predominant in females (46,530/232,650, 20.0%), and paracetamol use varies between GPs and rheumatologists. Conclusions: This health surveillance analysis provides a better understanding of the journey for patients with LBP or OA. These data confirmed that although paracetamol remains the most common first-line analgesic for patients with LBP and OA, usage varies among patients and health care specialists, and there are concerns over efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Paracetamol continues to occupy a privileged position within healthcare systems despite growing uncertainty regarding its efficacy in many chronic pain conditions [ 2 , 9 , 18 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“making paracetamol a paradigmatic example of the evidence-practice gap rather than an isolated case [ 18 , 57 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of major musculoskeletal conditions.
(2003) · Europe PMC (PubMed Central) · Cited by 3,521
Qaseem, A., Wilt, T. J., McLean, R. M., Forciea, M. A., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2367 · Cited by 3,234
OARSI guidelines for the non-surgical management of knee osteoarthritis
McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. M., Hawker, G. A., Henrotin, Y., Hunter, D. J., Kawaguchi, H., et al. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.01.003 · Cited by 3,110 · cited 1×
“Multiple guidelines, including the 2016 recommendations from the National Institute of Clinical Excellence (NICE) and the 2017 American College of Physicians clinical guidelines, advise against the use of paracetamol alone as a first-line therapy for acute LBP [17,55,63-65]; however, paracetamol is still recommended a…”
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41142 · Cited by 1,965
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Cui, A., Li, H., Wang, D., Zhong, J., Chen, Y., & Lu, H. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100587 · Cited by 1,614 · cited 1×
“Symptomatic knee OA is one of the more common forms of OA, experienced by approximately 22.9% of individuals over 40 years, and is a significant cause of disability [25,26].”
InfluentialBlagojevic, M., Jinks, C., Jeffery, A., & Jordan, K. P. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.08.010 · Cited by 1,397 · cited 1×
“owing to the degenerative nature of this disease that progresses with age [46,47].”
Chapter 3 European guidelines for the management of acute nonspecific low back pain in primary care
van Tulder, M., Becker, A., Bekkering, T., Breen, A., del Real, M. T. G., Hutchinson, A., Koes, B., Laerum, E., Malmivaara, A., & On behalf of the COST B13 Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care (2006) · European Spine Journal · doi:10.1007/s00586-006-1071-2 · Cited by 1,258
Nociplastic pain: towards an understanding of prevalent pain conditions
Fitzcharles, M.-A., Cohen, S. P., Clauw, D. J., Littlejohn, G., Usui, C., & Häuser, W. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00392-5 · Cited by 1,253 · cited 1×
“As such, it is important to identify the type of pain, as different therapies may be needed for appropriate management [62].”
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations
Sokolove, J., & Lepus, C. M. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12467868 · Cited by 1,100 · cited 1×
“However, these variations could also be attributed to the different underlying pain mechanisms involved (eg, chronic vs acute pain), with chronic inflammation predominant in patients with OA [49].”
Pharmacological Management of Persistent Pain in Older Persons
American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02376.x · Cited by 1,008
Martin, B. I., Mirza, S. K., Spina, N., Spiker, W. R., Lawrence, B., & Brodke, D. S. (2019) · Spine · doi:10.1097/brs.0000000000002822 · Cited by 917 · cited 1×
“3% between 1992 and 2006, and more patients seeking assistance from health care professionals (HCPs), the prevalence appears to be increasing [8].”
Osteoarthritis, angiogenesis and inflammation
Bonnet, C. S. (2005) · Rheumatology · doi:10.1093/rheumatology/keh344 · Cited by 709 · cited 1×
“Compressive forces, along with hypoxia, are believed to stimulate the development of nerves, causing pain even after inflammation has subsided [23].”
The Global Spine Care Initiative: a summary of the global burden of low back and neck pain studies
Hurwitz, E. L., Randhawa, K., Yu, H., Côté, P., & Haldeman, S. (2018) · European Spine Journal · doi:10.1007/s00586-017-5432-9 · Cited by 612 · cited 1×
“LBP, the most common musculoskeletal disorder, is experienced by approximately 38.0% of the general population, and is the leading cause of disability worldwide [5,6].”
InfluentialChou, R., & Huffman, L. H. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00008 · Cited by 583
Machado, G. C., Maher, C. G., Ferreira, P. H., Pinheiro, M. B., Lin, C.-W. C., Day, R. O., McLachlan, A. J., & Ferreira, M. L. (2015) · BMJ · doi:10.1136/bmj.h1225 · Cited by 580 · cited 1×
“In addition to being clinically ineffective in the treatment of LBP and OA, use of paracetamol can result in abnormal liver function test results compared with placebo [61].”
Determinants of disability in osteoarthritis of the knee
McAlindon, T. E., Cooper, C., Kirwan, J. R., & Dieppe, P. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.4.258 · Cited by 548 · cited 1×
“Symptomatic knee OA is one of the more common forms of OA, experienced by approximately 22.9% of individuals over 40 years, and is a significant cause of disability [25,26].”
InfluentialOr, Z., Gandré, C., Seppänen, A., Hernández‐Quevedo, C., Webb, E., Michel, M., & Chevreul, K. (2010) · PubMed · Cited by 412
Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial
Williams, C. M., Maher, C. G., Latimer, J., McLachlan, A. J., Hancock, M. J., Day, R. O., & Lin, C.-W. C. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60805-9 · Cited by 325
Zhang, W., Jones, A., & Doherty, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018531 · Cited by 321 · cited 1×
“Another meta-analysis review of 10 randomized controlled trials, including 1712 patients with OA, found that while NSAIDs were more effective than paracetamol for pain relief, paracetamol was still effective [59].”
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?
Laroche, M., Charmes, J., Nouaille, Y., Picard, N., & Merle, L. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02831.x · Cited by 317 · cited 1×
“Age-associated differences in drug sensitivities should also be considered when treating older patients [28,29].”
Chenot, J.-F., Greitemann, B., Kladny, B., Petzke, F., Pfingsten, M., & Schorr, S. G. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0883 · Cited by 282 · cited 1×
“The use of long-term analgesia for patients over 65 years remains challenging, and HCPs must weigh the benefits and risks given the potential increased risk of adverse effects in these patients [39,40].”
Lim, Y. Z., Chou, L., Au, R. T., Seneviwickrama, K. M. D., Cicuttini, F. M., Briggs, A. M., Sullivan, K., Urquhart, D. M., & Wluka, A. E. (2019) · Journal of Physiotherapy · doi:10.1016/j.jphys.2019.05.010 · Cited by 278 · cited 1×
“…guidelines recommending that they engage in shared decision-making, taking into consideration the needs of the patients, as well as their comorbidities, preferences, and values [69], and ensuring that patients receive enough information related to their condition in a clear and concise manner [70].”
Giustini, D. M., Ali, S. M., Fraser, M., & Boulos, M. N. K. (2018) · Online Journal of Public Health Informatics · doi:10.5210/ojphi.v10i2.8270 · Cited by 271 · cited 1×
“Social listening allows the exploration of this potentially valuable source of information [51,52].”
Ashraf, S., Wibberley, H., Mapp, P. I., Hill, R., Wilson, D., & Walsh, D. A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137844 · Cited by 229 · cited 1×
“Pain, mediated by a number of factors, including innervation and vascularization of the articular cartilage, is a principal symptom of OA [21,22].”
Infodemiology and Infoveillance: Scoping Review
Mavragani, A. (2020) · Journal of Medical Internet Research · doi:10.2196/16206 · Cited by 229 · cited 2×
“Reviewing the top 5 brand paracetamol agents used for the treatment of LBP, Doliprane was the most used (approximately 57.0% [52,440/92,000] and 64.0% [3840/6000] for GPs and rheumatologists, respectively), with GPs making more use of unbranded paracetamol and Bi-Profenid, compared with…”
InfluentialGanguly, P., El-Jawhari, J. J., Giannoudis, P. V., Burska, A. N., Ponchel, F., & Jones, E. A. (2017) · Cell Transplantation · doi:10.1177/0963689717721201 · Cited by 223
Risk factors for low back pain: A population-based longitudinal study
Shiri, R., Falah‐Hassani, K., Heliövaara, M., Solovieva, S., Amiri, S., Lallukka, T., Burdorf, A., Husgafvel‐Pursiainen, K., & Viikari‐Juntura, E. (2019) · Arthritis Care & Research · doi:10.1002/acr.23710 · Cited by 219 · cited 1×
“With 70.0% of the patients with LBP aged between 21 and 60 years, lifestyle and physical workload have been considered factors associated with an increased risk of LBP [48].”
InfluentialSaragiotto, B. T., Machado, G. C., Ferreira, M. L., Pinheiro, M. B., Abdel Shaheed, C., & Maher, C. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012230 · Cited by 215 · cited 1×
“Additionally, a meta-analysis review that included 1785 cases reported that paracetamol did not produce better outcomes than placebo for patients with LBP, including for scores of sleep, quality of life, or physical function [57].”
Kroenke, K., Outcalt, S., Krebs, E., Bair, M. J., Wu, J., Chumbler, N., & Yu, Z. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.03.020 · Cited by 212 · cited 2×
“It is affected by, but not limited to, their mood, sleep patterns, and avoidance behavior [2,67,68].”
Chronic back pain and its association with quality of life in a large French population survey
Husky, M. M., Ferdous Farin, F., Compagnone, P., Fermanian, C., & Kovess-Masfety, V. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-1018-4 · Cited by 202 · cited 1×
“LBP, the most common musculoskeletal disorder, is experienced by approximately 38.0% of the general population, and is the leading cause of disability worldwide [5,6].”
InfluentialDiagnosis and management of acute low back pain.
Patel, A. T., & Ogle, A. A. (2000) · PubMed · Cited by 159
Chronic musculoskeletal pain in European older adults: Cross‐national and gender differences
Cimas, M., Ayala, A., Sanz, B., Agulló‐Tomás, M. S., Escobar, A., & Forjaz, M. J. (2018) · European Journal of Pain · doi:10.1002/ejp.1123 · Cited by 156 · cited 1×
“In line with this finding, a study in France assessing chronic musculoskeletal pain found a higher prevalence in women (41%, 95% CI 40.2-42.4) than in men (29%, 95% CI 28.0-30.3) [45].”
InfluentialBoth cladribine and alemtuzumab may effect MS via B-cell depletion
Baker, D., Herrod, S. S., Álvarez-González, C., Zalewski, L., Albor, C., & Schmierer, K. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000360 · Cited by 152 · cited 1×
“Invasive surgery is usually the last option and is considered on a case-by-case basis (Table 1) [12,14-19].”
Acute mechanical injury of the human intervertebral disc: link to degeneration and pain
Alkhatib, B., Rosenzweig, D., Krock, E., Roughley, P. J., Beckman, L., Steffen, T., Weber, M., Ouellet, J., & Haglund, L. (2014) · European Cells and Materials · doi:10.22203/ecm.v028a08 · Cited by 124 · cited 1×
“…such as strenuous physical activities like lifting, pushing, or pulling a heavy load, with pain intensity ranging from sharp shooting pain, arising during sudden strenuous activity, to chronic pain that develops slowly over time as a result of degenerative changes within the spinal cord [9,10].”
Diagnostic therapeutic flow-charts for low back pain patients: the Italian clinical guidelines.
Négrini, S., Giovannoni, S., Minozzi, S., Barneschi, G., Bonaiuti, D., Bussotti, A., D’Arienzo, M., Lorenzo, N. D., Mannoni, A., Mattioli, S., et al. (2006) · PubMed · Cited by 119
Barriers and progress in the treatment of low back pain
Foster, N. E. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-108 · Cited by 114 · cited 1×
“For patients with acute nonspecific LBP, effective treatment remains a challenge [12,13].”
Non-specific Low Back Pain and Postural Control During Quiet Standing—A Systematic Review
Koch, C., & Hänsel, F. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00586 · Cited by 109 · cited 1×
“However, the vast majority of cases are classified as acute nonspecific, as no definitive cause can be identified, and this will be the focus of this study [11].”
Sora, T. J., Fisker, A., Juhl, C. B., & Petersen, T. (2018) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-018-2351-9 · Cited by 108 · cited 1×
“It is affected by, but not limited to, their mood, sleep patterns, and avoidance behavior [2,67,68].”
Sellam, J., Courties, A., Eymard, F., Ferrero, S., Latourte, A., Ornetti, P., Bannwarth, B., Baumann, L., Berenbaum, F., Chevalier, X., et al. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.09.004 · Cited by 105 · cited 2×
“Topical agents and intra-articular treatments have also been recommended (Table 2) [27].”
Mork, P. J., Vik, K. L., Moe, B., Lier, R., Bardal, E. M., & Nilsen, T. I. L. (2013) · European Journal of Public Health · doi:10.1093/eurpub/ckt198 · Cited by 103 · cited 1×
“It is affected by, but not limited to, their mood, sleep patterns, and avoidance behavior [2,67,68].”
Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?
Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00658-9 · Cited by 101
Osteoarthritis: the cause not result of joint failure?
Hutton, C. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.11.958 · Cited by 84 · cited 1×
“…back pain: A clinical practice guideline from the American College of Physicians (ACP) [12] OA OA is characterized by the progressive destruction of articular cartilage associated with subchondral bone remodeling, formation of osteophytes, and secondary inflammation of synovial membranes [20,21].”
Paracetamol in osteoarthritis of the knee
Miceli‐Richard, C., Bars, M. L., Schmidely, N., & Dougados, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017236 · Cited by 83 · cited 1×
“A high proportion of patients discontinue prescription analgesics within the first few months due to inadequate pain relief or intolerable side effects [41,42].”
The Role of Paracetamol in Chronic Pain: An Evidence-Based Approach
Nikles, J., Yelland, M. J., Mar, C. D., & Wilkinson, D. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00011 · Cited by 82 · cited 1×
“Interestingly, a 2005 meta-analysis review found that paracetamol use was an effective pain management approach for patients with chronic pain, with a favorable safety profile compared with NSAIDs, recommending that paracetamol be used as an NSAID sparer [58].”
Lapane, K. L., Yang, S., Driban, J. B., Liu, S., Dube, C. E., McAlindon, T. E., & Eaton, C. B. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38933 · Cited by 69 · cited 1×
“A high proportion of patients discontinue prescription analgesics within the first few months due to inadequate pain relief or intolerable side effects [41,42].”
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis
Anderson, L., Bell, H., Gilbert, M. K., Davidson, J. E., Winter, C., Barratt, M. J., Win, B., Painter, J. L., Menone, C. M., Sayegh, J., et al. (2017) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.6174 · Cited by 56
Robertson, D. B., Kumbhare, D. A., Nolet, P. S., Srbely, J. Z., & Newton, G. S. (2017) · PubMed Central · Cited by 54
Changes in Aβ Non-Nociceptive Primary Sensory Neurons in a Rat Model of Osteoarthritis Pain
Wu, Q., & Henry, J. L. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-37 · Cited by 43
Stefano, N. D., Barkhof, F., Montalbán, X., Achiron, A., Derfuss, T., Chan, A., Hodgkinson, S. J., Prat, A., Leocani, L., Schmierer, K., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001187 · Cited by 39
Characterization of Joint Pain in Human OA
Ordeberg, G. (2004) · Novartis Foundation symposium · doi:10.1002/0470867639.ch8 · Cited by 38
Analgesics and Osteoarthritis: Are Treatment Guidelines Reflected in Clinical Practice?
Jawad, A. S. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00013 · Cited by 38 · cited 1×
“0% of patients had switched from an NSAID due to side effects [56].”
Yajima, M., Sugimoto, M., Sugimura, Y. K., Takahashi, Y., & Kato, F. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109029 · Cited by 21
Spinal Fusion for Chronic Low Back Pain: A 'Magic Bullet' or Wishful Thinking?
Dhillon, K. S. (2016) · Europe PMC (PubMed Central) · Cited by 20
Schück, S., Roustamal, A., Gedik, A., Voillot, P., Foulquié, P., Penfornis, C., & Job, B. (2021) · Journal of Medical Internet Research · doi:10.2196/25049 · Cited by 18 · cited 1×
“This is backed up by an infodemiology study analyzing 44,283 social media posts, in which Doliprane was the most mentioned paracetamol with 31.7% of posts, followed by Dafalgan with 10.9% of posts and Ixprim with 9.8% of posts [38].”
InfluentialGrézy-Chabardès, C., Fournier, J., Dupouy, J., Poutrain, J.-C., & Oustric, S. (2015) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2015.1082007 · Cited by 16
Paracetamol for low back pain: the state of the research field
Koes, B. W., Schreijenberg, M., & Tkachev, A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1817738 · Cited by 15 · cited 1×
“…hip, and knee [31] The Role of Paracetamol Given the similarities in the initial treatment recommendations for both LBP and OA, paracetamol is the most commonly employed first-line analgesic for both conditions, used by over 94.4% of patients with LBP and over 96.0% of patients with OA [32-35].”
InfluentialThe Medical Drug as a Technological Object
Simón, J. (2019) · Techné Research in Philosophy and Technology · doi:10.5840/techne201951395 · Cited by 1 · cited 1×
“There are a variety of paracetamol brands available in France, and Doliprane is the most prescribed paracetamol (Table 3) [36,37].”
Research works printed but not linked: 10
- Woolf, AD, 2003, Bull World Health Organ, 81, 646
- Robertson, D, 2017, J Can Chiropr Assoc, 61, 96
- Patel, AT, 2000, Am Fam Physician, 61, 1779
- Dhillon, KS, 2016, Malays Orthop J, 10, 61
- 2016, Low Back Pain and Sciatica in Over 16s: Assessment and Management
- Ordeberg, G, 2004, Osteoarthritic Joint Pain: Novartis Foundation Symposium 260, Volume 260
- 2014, Care and Management in Adults
- Chevreul, K, 2015, Health Syst Transit, 17, 1
- Negrini, S, 2006, Eura Medicophys, 42, 151
- 10.7326/m16-2367 · DOI · Paper page
Cited by
DNA Supramolecular Hydrogel-Enabled Sustained Delivery of Metformin for Relieving Osteoarthritis
Zhang, C., Huang, H., Chen, J., Zuo, T., Ou, Q., Ruan, G., He, J., & Ding, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20496 · Cited by 40
Cao, Z., Han, K., Lu, H., Illangamudalige, S., Shaheed, C. A., Chen, L., McLachlan, A. J., Patanwala, A. E., Maher, C. G., Lin, C. C., et al. (2024) · Drugs · doi:10.1007/s40265-024-02065-w · Cited by 37
The Challenges of Pain Assessment in Geriatric Patients With Dementia: A Review
El-Tallawy, S. N., Ahmed, R. S., Shabi, S. M., Al-Zabidi, F. Z., Zaidi, A. R. Z., Varrassi, G., Pergolizzi, J. V., LeQuang, J. A., & Paladini, A. (2023) · Cureus · doi:10.7759/cureus.49639 · Cited by 31
“The nonsteroidal anti-inflammatory drugs (NSAIDs) are not recommended in this age group because of the associated side effects on the cardiovascular system, renal impairment, and the increased risk of gastrointestinal bleeding [22].”
BackgroundNeuropharmacology of Neuropathic Pain: A Systematic Review
Mian, M. U., Afzal, M., Butt, A. A., Ijaz, M., Khalil, K., Abbasi, M., Fatima, M., Asif, M. F., Nadeem, S., Jha, S., et al. (2024) · Cureus · doi:10.7759/cureus.69028 · Cited by 25
“Paracetamol is the first-line therapy for patients with OA [59].”
BackgroundChen, S., Xu, H., He, Y., Meng, C., Fan, Y., Qu, Y., Wang, Y.-G., Zhou, W., Huang, X., & You, H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110781 · Cited by 12
Metadata
- Authors
- Pickering, G., Mezouar, L., Kechemir, H., & Ebel-Bitoun, C.
- Affiliations
- Sanofi (France) (FR)
- Venue
- JMIR Public Health and Surveillance
- Publisher
- JMIR Publications Inc.
- Published
- 2022-10-27
- Volume
- 8
- Issue
- 10
- Pages
- e37790
- ISSN
- 2369-2960 (ISSN-L)
- PMC
- PMC9650576
- OpenAlex
- W4307444501
- Cited by
- 9
- References
- 61
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 5
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Public Health and Surveillance (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- paracetamol, osteoarthritis, low back pain, musculoskeletal pain, prescribing patterns, first-line therapy, nonsteroidal anti-inflammatory drugs, general practitioners, rheumatologists, infodemiology, Twitter, online health communities, real-world data, France, United States
- MeSH terms
- Acetaminophen, Infodemiology, Adult, Female, Humans, Male, Osteoarthritis, Retrospective Studies, Low Back Pain, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.